<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39331947</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>39</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>The influence of COVID-19 on short-term mortality in acute ischemic stroke: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e39761</StartPage><MedlinePgn>e39761</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39761</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039761</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the differences in short-term mortality risk between acute ischemic stroke (AIS) patients with and without SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, EMBASE, Scopus, and Cochrane Databases were systematically searched from December 1, 2019 to May 20, 2022 using the keywords coronavirus disease 2019 (COVID-19), COVID-19, SARS-CoV-2, and ischemic stroke. A random-effects model was estimated, and subgroup analysis and meta-regressions were performed. The quality of eligible studies was assessed using the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 26 eligible studies with 307,800 patients were included in this meta-analysis. The overall results show that in-hospital and 90-day mortality was 3.31-fold higher in AIS with SARS-CoV-2 patients compared with those without SARS-CoV-2. When matched for age and National Institutes of Health Stroke Scale score at admission, the risk ratio of in-hospital mortality from AIS among patients with SARS-CoV-2 versus without decreased to 2.83. Reperfusion therapy and endovascular thrombectomy may further reduce the risk of death in patients to some extent but do not increase the incidence of symptomatic intracerebral hemorrhage. Meta-regression showed that in-hospital mortality decreased with increasing National Institutes of Health Stroke Scale score in AIS with SARS-CoV-2 compared to those without SARS-CoV-2 and that the difference in mortality risk between the 2 was independent of age and sex.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of this study suggest that AIS patients with SARS-CoV-2 have higher short-term mortality compared to AIS patients without SARS-CoV-2, and reperfusion and endovascular thrombectomy therapy may reduce the risk of short-term mortality to some extent. The differences in in-hospital mortality risk were similar across ages and sexes. Focused attention is therefore needed on AIS patients with SARS-CoV-2 to control mortality.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yi-Dong</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Yan'an University Affiliated Hospital, Yan'an, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Ying-Ying</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory, Yan'an University Affiliated Hospital, Yan'an, Shaanxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Medicine, Medical School of Yan'an University, Yan'an, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Chan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Yan'an University Affiliated Hospital, Yan'an, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-7354-5234</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Yan'an University Affiliated Hospital, Yan'an, Shaanxi, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>18</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39331947</ArticleId><ArticleId IdType="pmc">PMC11441880</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039761</ArticleId><ArticleId IdType="pii">00005792-202409270-00090</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghio D, Bignami-Van Assche S, Stilianakis NI. Demographics of COVID-19 hospitalisations and related fatality risk patterns. Health Policy. 2022;126:945–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308136</ArticleId><ArticleId IdType="pubmed">35927091</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakili K, Fathi M, Pezeshgi A, et al. . Critical complications of COVID-19: a descriptive meta-analysis study. Rev Cardiovasc Med. 2020;21:433–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">33070547</ArticleId></ArticleIdList></Reference><Reference><Citation>Mughees M, Chugh H, Naqvi SH, Wajid S. COVID-19 threat to the world: current and possible diagnostic/treatment strategies. Crit Rev Biomed Eng. 2021;49:21–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">34347985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YD, Ding M, Dong X, et al. . Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76:428–55.</Citation><ArticleIdList><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandia R, Singhal S, Alqahtani T, et al. . Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022;209:112816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798788</ArticleId><ArticleId IdType="pubmed">35093310</ArticleId></ArticleIdList></Reference><Reference><Citation>Batah SS, Fabro AT. Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians. Respir Med. 2021;176:106239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674971</ArticleId><ArticleId IdType="pubmed">33246294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Li Y, Ge Y, et al. . Evaluation of nutrition risk and its association with mortality risk in severely and critically ill COVID-19 patients. JPEN J Parenter Enteral Nutr. 2021;45:32–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361906</ArticleId><ArticleId IdType="pubmed">32613660</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangayach NS, Newcombe V, Sonnenville R. Acute neurologic complications of COVID-19 and postacute sequelae of COVID-19. Crit Care Clin. 2022;38:553–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8940578</ArticleId><ArticleId IdType="pubmed">35667743</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiri HA, Razavi AS, Tabrizi N, et al. . The effects of COVID-19 on patients with acute ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis. 2022;31:106512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015955</ArticleId><ArticleId IdType="pubmed">35489184</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar N, Abid FB, Kamran S, et al. . Characteristics and comparison of 32 COVID-19 and Non-COVID-19 ischemic strokes and historical stroke patients. J Stroke Cerebrovasc Dis. 2021;30:105435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605738</ArticleId><ArticleId IdType="pubmed">33171425</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Kasab S, Almallouhi E, Alawieh A, et al. . International experience of mechanical thrombectomy during the COVID-19 pandemic: insights from STAR and ENRG. J Neurointerv Surg. 2020;12:1039–44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453763</ArticleId><ArticleId IdType="pubmed">32843359</ArticleId></ArticleIdList></Reference><Reference><Citation>Benny R, Singh RK, Venkitachalam A, et al. . Characteristics and outcomes of 100 consecutive patients with acute stroke and COVID-19. J Neurol Sci. 2021;423:117348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887446</ArticleId><ArticleId IdType="pubmed">33636660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia R, Padma Srivastava MV, Sylaja PN, et al. . Clinical features and outcome of stroke with COVID-19. COVID-19 Stroke Study Group (CSSG), India. Ann Indian Acad Neurol. 2021;24:668–85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8680894</ArticleId><ArticleId IdType="pubmed">35002124</ArticleId></ArticleIdList></Reference><Reference><Citation>Calmettes J, Peres R, Goncalves B, et al. . Clinical outcome of acute ischemic strokes in patients with COVID-19. Cerebrovasc Dis. 2021;50:412–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8089450</ArticleId><ArticleId IdType="pubmed">33784669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciolli L, Righi V, Vandelli G, et al. . In-hospital and out-of-hospital stroke in patients with COVID-19: two different diseases? Neurol Sci. 2022;43:2203–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782697</ArticleId><ArticleId IdType="pubmed">35064343</ArticleId></ArticleIdList></Reference><Reference><Citation>de Havenon A, Ney JP, Callaghan B, et al. . Characteristics and outcomes among US patients hospitalized for ischemic stroke before vs during the COVID-19 pandemic. JAMA Netw Open. 2021;4:e2110314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129817</ArticleId><ArticleId IdType="pubmed">33999162</ArticleId></ArticleIdList></Reference><Reference><Citation>de Havenon A, Yaghi S, Mistry EA, et al. . Endovascular thrombectomy in acute ischemic stroke patients with COVID-19: prevalence, demographics, and outcomes. J Neurointerv Surg. 2020;12:1045–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523171</ArticleId><ArticleId IdType="pubmed">32989032</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirelli DS, Genc G, Basarir CI, Bulut S. Comparison of clinical characteristics of COVID-19-related and unrelated acute stroke patients during the COVID-19 pandemic in Turkey. Sisli Etfal Hastan Tip Bul. 2022;56:55–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9040310</ArticleId><ArticleId IdType="pubmed">35515970</ArticleId></ArticleIdList></Reference><Reference><Citation>Escalard S, Chalumeau V, Escalard C, et al. . Early brain imaging shows increased severity of acute ischemic strokes with large vessel occlusion in COVID-19 patients. Stroke. 2020;51:3366–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7446979</ArticleId><ArticleId IdType="pubmed">32813602</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes B, Alonso de Leciñana M, García-Madrona S, et al. . Stroke acute management and outcomes during the COVID-19 outbreak: a cohort study from the madrid stroke network. Stroke. 2021;52:552–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">33406872</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabet A, Grave C, Chatignoux E, Tuppin P, Béjot Y, Olié V. Characteristics, management, and case-fatality of patients hospitalized for stroke with a diagnosis of COVID-19 in France. Neuroepidemiology. 2021;55:323–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339027</ArticleId><ArticleId IdType="pubmed">34167111</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbour P, Dmytriw AA, Sweid A, et al. . Characteristics of a COVID-19 cohort with large vessel occlusion: a multicenter international study. Neurosurgery. 2022;90:725–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514728</ArticleId><ArticleId IdType="pubmed">35238817</ArticleId></ArticleIdList></Reference><Reference><Citation>Martí-Fàbregas J, Guisado-Alonso D, Delgado-Mederos R, et al. .; COVICTUS Collaborators. Impact of COVID-19 infection on the outcome of patients with ischemic stroke. Stroke. 2021;52:3908–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607902</ArticleId><ArticleId IdType="pubmed">34455823</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry RJ, Smith CJ, Roffe C, et al. .; SETICOS collaborators. Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. J Neurol Neurosurg Psychiatry. 2021;92:242–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33154179</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Grassi M, Silvestrelli G, et al. .; STROKOVID group. SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy. J Neurol. 2022;269:1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142879</ArticleId><ArticleId IdType="pubmed">34031747</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Grassi M, Silvestrelli G, et al. .; STROKOVID group. Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network. J Neurol. 2021;268:3561–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937781</ArticleId><ArticleId IdType="pubmed">33683456</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, et al. . Utilization and outcomes of acute revascularization treatments in ischemic stroke patients with SARS-CoV-2 infection. J Stroke Cerebrovasc Dis. 2022;31:106157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8498748</ArticleId><ArticleId IdType="pubmed">34689049</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter D, Krogias C, Eyding J, Bartig D, Grau A, Weber R. Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis. Neurol Res Pract. 2020;2:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675387</ArticleId><ArticleId IdType="pubmed">33230500</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasanejad P, Afshar Hezarkhani L, Arsang-Jang S, et al. . Safety and outcomes of intravenous thrombolytic therapy in ischemic stroke patients with COVID-19: CASCADE initiative. J Stroke Cerebrovasc Dis. 2021;30:106121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450304</ArticleId><ArticleId IdType="pubmed">34601242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawczyńska K, Wrona P, Kęsek T, et al. . Mechanical thrombectomy in COVID-19-associated ischaemic stroke: patient characteristics and outcomes in a single-centre study. Neurol Neurochir Pol. 2022;56:163–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">35315928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobolewski P, Antecki J, Brola W, Fudala M, Bieniaszewski L, Kozera G. Systemic thrombolysis in ischaemic stroke patients with COVID-19. Acta Neurol Scand. 2022;145:47–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444791</ArticleId><ArticleId IdType="pubmed">34415051</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava PK, Zhang S, Xian Y, et al. . Acute ischemic stroke in patients with COVID-19: an analysis from get with the guidelines-stroke. Stroke. 2021;52:1826–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33728926</ArticleId></ArticleIdList></Reference><Reference><Citation>Strambo D, De Marchis GM, Bonati LH, et al. .; Swiss Stroke Registry Investigators. Ischemic stroke in COVID-19 patients: mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis. Eur J Neurol. 2022;29:732–43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9299927</ArticleId><ArticleId IdType="pubmed">34845794</ArticleId></ArticleIdList></Reference><Reference><Citation>PROSPERO. Clinical prognosis and influencing factors of COVID-19 positive AIS patients: a systematic review and meta-analysis.
Available at: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=337425. [access date June 6, 2022].</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2020;29:2520–37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390706</ArticleId><ArticleId IdType="pubmed">32292115</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharthy A, Aletreby W, Faqihi F, et al. . Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study. J Epidemiol Glob Health. 2021;11:98–104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7958266</ArticleId><ArticleId IdType="pubmed">33095982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardamean E, Roan W, Iskandar KTA, Prayangga R, Hariyanto TI. Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2022;75:61–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813760</ArticleId><ArticleId IdType="pubmed">35182908</ArticleId></ArticleIdList></Reference><Reference><Citation>Biarnés-Suñé A, Solà-Enríquez B, González Posada MA, Teixidor-Serra J, García-Sánchez Y, Manrique Muñóz S. Impact of the COVID-19 pandemic on the mortality of the elderly patient with a hip fracture. Rev Esp Anestesiol Reanim (Engl Ed). 2021;68:65–72. English, Spanish.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577732</ArticleId><ArticleId IdType="pubmed">33461768</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Ren J, Hou H, et al. . The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates. Neurol Sci. 2022;43:4049–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943353</ArticleId><ArticleId IdType="pubmed">35325320</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein LK, Mayman NA, Dhamoon MS, Fifi JT. The emerging association between COVID-19 and acute stroke. Trends Neurosci. 2021;44:527–37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026270</ArticleId><ArticleId IdType="pubmed">33879319</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos AH, Palaiodimou L, Zand R, et al. . The impact of SARS-CoV-2 on stroke epidemiology and care: a meta-analysis. Ann Neurol. 2021;89:380–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753413</ArticleId><ArticleId IdType="pubmed">33219563</ArticleId></ArticleIdList></Reference><Reference><Citation>Linfante I, Starosciak AK, Walker GR, et al. . Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry. J Neurointerv Surg. 2016;8:224–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25564538</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi-Hokmabadi E, Yazdchi M, Farhoudi M, et al. . Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: the first study among Iranian patients. Iran J Neurol. 2018;17:31–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6121208</ArticleId><ArticleId IdType="pubmed">30186557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Lee DS, Nah HW, Cha J-K. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke. BMC Neurol. 2018;18:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856376</ArticleId><ArticleId IdType="pubmed">29544461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Bai Q, Ren H, et al. . Effectiveness and predictors of poor prognosis following intravenous thrombolysis in patients with wake-up ischemic stroke guided by rapid MRI. Neuropsychiatr Dis Treat. 2022;18:317–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860628</ArticleId><ArticleId IdType="pubmed">35210778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonarow GC, Saver JL, Smith EE, et al. . Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J Am Heart Assoc. 2012;1:42–50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3487316</ArticleId><ArticleId IdType="pubmed">23130117</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawodu CO, Danesi MA. Relationship of National Institute of Health Stroke Scores [NIHSS] to 90 days mortality in Africa. Niger Postgrad Med J. 2008;15:259–63.</Citation><ArticleIdList><ArticleId IdType="pubmed">19169345</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooque U, Lohano AK, Kumar A, et al. . Validity of National Institutes of Health Stroke scale for severity of stroke to predict mortality among patients presenting with symptoms of stroke. Cureus. 2020;12:e10255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536102</ArticleId><ArticleId IdType="pubmed">33042693</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, et al. . Acute ischemic stroke and COVID-19: an analysis of 27 676 patients. Stroke. 2021;52:905–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903982</ArticleId><ArticleId IdType="pubmed">33535779</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>